{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:28:59Z","timestamp":1790882939528,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T00:00:00Z","timestamp":1537401600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Association francaise developement de la stomatologie"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13023-018-0907-2","type":"journal-article","created":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T06:42:15Z","timestamp":1537425735000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Molecular and cellular characterizations of human cherubism: disease aggressiveness depends on osteoclast differentiation"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5961-4064","authenticated-orcid":false,"given":"Natacha","family":"Kadlub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Sessiecq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Mandavit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore Coulomb","family":"L\u2019Hermine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Badoual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Galmiche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"Berdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vianney","family":"Descroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie E.","family":"Coudert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,20]]},"reference":[{"key":"907_CR1","first-page":"334","volume":"32\u2013B","author":"J Wa","year":"1950","unstructured":"Wa J, Gerrie J, Pritchard J. Cherubism--familial fibrous dysplasia of the jaws. J Bone Joint Surg Br. 1950;32\u2013B:334\u201347.","journal-title":"J Bone Joint Surg Br"},{"key":"907_CR2","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0278-2391(92)90333-U","volume":"50","author":"JO Katz","year":"1992","unstructured":"Katz JO, Dunlap CL, Ennis RL. Cherubism: report of a case showing regression without treatment. J Oral Maxillofac Surg. 1992;50:301\u20133.","journal-title":"J Oral Maxillofac Surg"},{"key":"907_CR3","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/ppul.22686","volume":"48","author":"S Khirani","year":"2013","unstructured":"Khirani S, Kadlub N, Delord V, Picard A, Fauroux B. Nocturnal mouthpiece ventilation and medical hypnosis to treat severe obstructive sleep apnea in a child with cherubism. Pediatr Pulmonol. 2013;48:927\u20139. \n                    https:\/\/doi.org\/10.1002\/ppul.22686\n                    \n                  .","journal-title":"Pediatr Pulmonol"},{"issue":"5","key":"907_CR4","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1002\/jbmr.2431","volume":"30","author":"Natacha Kadlub","year":"2015","unstructured":"Kadlub N, Vazquez M-P, Galmiche L, L\u2019Hermin\u00e9 AC, Dainese L, Ulinski T, et al. The calcineurin inhibitor tacrolimus as a new therapy in severe cherubism. J Bone Miner Res. 2014. \n                    https:\/\/doi.org\/10.1002\/jbmr.2431\n                    \n                  .","journal-title":"Journal of Bone and Mineral Research"},{"key":"907_CR5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/modpathol.3880527","volume":"15","author":"JA Regezi","year":"2002","unstructured":"Regezi JA. Odontogenic cysts, odontogenic tumors, fibroosseous, and giant cell lesions of the jaws. Mod Pathol. 2002;15:331\u201341. \n                    https:\/\/doi.org\/10.1038\/modpathol.3880527\n                    \n                  .","journal-title":"Mod Pathol"},{"key":"907_CR6","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s002560050530","volume":"28","author":"T Yamaguchi","year":"1999","unstructured":"Yamaguchi T, Dorfman HD, Eisig S. Cherubism: clinicopathologic features. Skelet Radiol. 1999;28:350\u20133.","journal-title":"Skelet Radiol"},{"key":"907_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/88832","volume":"28","author":"Y Ueki","year":"2001","unstructured":"Ueki Y, Tiziani V, Santanna C, Fukai N, Maulik C, Garfinkle J, et al. Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism. Nat Genet. 2001;28:125\u20136. \n                    https:\/\/doi.org\/10.1038\/88832\n                    \n                  .","journal-title":"Nat Genet"},{"key":"907_CR8","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S1074-7613(00)80657-3","volume":"9","author":"M Deckert","year":"1998","unstructured":"Deckert M, Tartare-Deckert S, Hernandez J, Rottapel R, Altman A. Adaptor function for the Syk kinases-interacting protein 3BP2 in IL-2 gene activation. Immunity. 1998;9:595\u2013605.","journal-title":"Immunity"},{"key":"907_CR9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/0-387-34132-3_8","volume":"584","author":"M Deckert","year":"2006","unstructured":"Deckert M, Rottapel R. The adapter 3BP2: how it plugs into leukocyte signaling. Adv Exp Med Biol. 2006;584:107\u201314. \n                    https:\/\/doi.org\/10.1007\/0-387-34132-3_8\n                    \n                  .","journal-title":"Adv Exp Med Biol"},{"key":"907_CR10","doi-asserted-by":"publisher","first-page":"24912","DOI":"10.1074\/jbc.M301201200","volume":"278","author":"K Maeno","year":"2003","unstructured":"Maeno K, Sada K, Kyo S, Miah SMS, Kawauchi-Kamata K, Qu X, et al. Adaptor protein 3BP2 is a potential ligand of Src homology 2 and 3 domains of Lyn protein-tyrosine kinase. J Biol Chem. 2003;278:24912\u201320. \n                    https:\/\/doi.org\/10.1074\/jbc.M301201200\n                    \n                  .","journal-title":"J Biol Chem"},{"key":"907_CR11","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1182\/blood-2003-08-2965","volume":"105","author":"I Foucault","year":"2004","unstructured":"Foucault I. The adaptor protein 3BP2 associates with VAV guanine nucleotide exchange factors to regulate NFAT activation by the B-cell antigen receptor. Blood. 2004;105:1106\u201313. \n                    https:\/\/doi.org\/10.1182\/blood-2003-08-2965\n                    \n                  .","journal-title":"Blood"},{"key":"907_CR12","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1128\/MCB.01014-06","volume":"27","author":"G Chen","year":"2007","unstructured":"Chen G, Dimitriou ID, La Rose J, Ilangumaran S, Yeh W-C, Doody G, et al. The 3BP2 adapter protein is required for optimal B-cell activation and thymus-independent type 2 Humoral response. Mol Cell Biol. 2007;27:3109\u201322. \n                    https:\/\/doi.org\/10.1128\/MCB.01014-06\n                    \n                  .","journal-title":"Mol Cell Biol"},{"key":"907_CR13","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.1172\/JCI45843","volume":"121","author":"N Levaot","year":"2011","unstructured":"Levaot N, Simoncic PD, Dimitriou ID, Scotter A, La Rose J, Ng AHM, et al. 3BP2-deficient mice are osteoporotic with impaired osteoblast and osteoclast functions. J Clin Invest. 2011;121:3244\u201357. \n                    https:\/\/doi.org\/10.1172\/JCI45843\n                    \n                  .","journal-title":"J Clin Invest"},{"key":"907_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cell.2006.10.047","volume":"128","author":"Y Ueki","year":"2007","unstructured":"Ueki Y, Lin C-Y, Senoo M, Ebihara T, Agata N, Onji M, et al. Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 \u2018cherubism\u2019 mice. Cell. 2007;128:71\u201383. \n                    https:\/\/doi.org\/10.1016\/j.cell.2006.10.047\n                    \n                  .","journal-title":"Cell"},{"key":"907_CR15","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.1172\/JCI35711","volume":"118","author":"AO Aliprantis","year":"2008","unstructured":"Aliprantis AO, Ueki Y, Sulyanto R, Park A, Sigrist KS, Sharma SM, et al. NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism. J Clin Invest. 2008;118:3775\u201389. \n                    https:\/\/doi.org\/10.1172\/JCI35711\n                    \n                  .","journal-title":"J Clin Invest"},{"key":"907_CR16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.clim.2012.12.012","volume":"147","author":"H Morbach","year":"2013","unstructured":"Morbach H, Hedrich CM, Beer M, Girschick HJ. Autoinflammatory bone disorders. Clin Immunol. 2013;147:185\u201396. \n                    https:\/\/doi.org\/10.1016\/j.clim.2012.12.012\n                    \n                  .","journal-title":"Clin Immunol"},{"key":"907_CR17","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.rdc.2013.05.002","volume":"39","author":"SM Stern","year":"2013","unstructured":"Stern SM, Ferguson PJ. Autoinflammatory bone diseases. Rheum Dis Clin N Am. 2013;39:735\u201349. \n                    https:\/\/doi.org\/10.1016\/j.rdc.2013.05.002\n                    \n                  .","journal-title":"Rheum Dis Clin N Am"},{"key":"907_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00441-009-0874-y","volume":"339","author":"C Nicolae","year":"2010","unstructured":"Nicolae C, Olsen BR. Unexpected matrix diseases and novel therapeutic strategies. Cell Tissue Res. 2010;339:155\u201365. \n                    https:\/\/doi.org\/10.1007\/s00441-009-0874-y\n                    \n                  .","journal-title":"Cell Tissue Res"},{"key":"907_CR19","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.humpath.2016.07.019","volume":"58","author":"N Kadlub","year":"2016","unstructured":"Kadlub N, Sessiecq Q, Dainese L, Joly A, Lehalle D, Marlin S, et al. Defining a new aggressiveness classification and using NFATc1 localization as a prognostic factor in cherubism. Hum Pathol. 2016;58:62\u201371. \n                    https:\/\/doi.org\/10.1016\/j.humpath.2016.07.019\n                    \n                  .","journal-title":"Hum Pathol"},{"key":"907_CR20","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1097\/01.sap.0000248141.36904.19","volume":"58","author":"CE Raposo-Amaral","year":"2007","unstructured":"Raposo-Amaral CE, de Campos Guidi M, Warren SM, Almeida AB, Amstalden EMI, Tiziane V, et al. Two-stage surgical treatment of severe cherubism. Ann Plast Surg. 2007;58:645\u201351. \n                    https:\/\/doi.org\/10.1097\/01.sap.0000248141.36904.19\n                    \n                  .","journal-title":"Ann Plast Surg"},{"key":"907_CR21","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1034\/j.1600-0714.2003.00126.x","volume":"32","author":"B Liu","year":"2003","unstructured":"Liu B, Yu S-F, Li T-J. Multinucleated giant cells in various forms of giant cell containing lesions of the jaws express features of osteoclasts. J Oral Pathol Med. 2003;32:367\u201375.","journal-title":"J Oral Pathol Med"},{"key":"907_CR22","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1136\/jcp.51.11.831","volume":"51","author":"J Southgate","year":"1998","unstructured":"Southgate J, Sarma U, Townend JV, Barron J, Flanagan AM. Study of the cell biology and biochemistry of cherubism. J Clin Pathol. 1998;51:831\u20137.","journal-title":"J Clin Pathol"},{"key":"907_CR23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/labinvest.2013.140","volume":"94","author":"AE Coudert","year":"2014","unstructured":"Coudert AE, Del Fattore A, Baulard C, Olaso R, Schiltz C, Collet C, et al. Differentially expressed genes in autosomal dominant osteopetrosis type II osteoclasts reveal known and novel pathways for osteoclast biology. Lab Investig. 2014;94:275\u201385. \n                    https:\/\/doi.org\/10.1038\/labinvest.2013.140\n                    \n                  .","journal-title":"Lab Investig"},{"key":"907_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s11154-014-9308-6","volume":"16","author":"TJ Martin","year":"2015","unstructured":"Martin TJ, Sims NA. RANKL\/OPG; critical role in bone physiology. Rev Endocr Metab Disord. 2015;16:131\u20139. \n                    https:\/\/doi.org\/10.1007\/s11154-014-9308-6\n                    \n                  .","journal-title":"Rev Endocr Metab Disord"},{"key":"907_CR25","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1016\/j.celrep.2014.08.023","volume":"8","author":"T Yoshitaka","year":"2014","unstructured":"Yoshitaka T, Mukai T, Kittaka M, Alford LM, Masrani S, Ishida S, et al. Enhanced TLR-MYD88 signaling stimulates autoinflammation in SH3BP2 cherubism mice and defines the etiology of cherubism. Cell Rep. 2014;8:1752\u201366. \n                    https:\/\/doi.org\/10.1016\/j.celrep.2014.08.023\n                    \n                  .","journal-title":"Cell Rep"},{"key":"907_CR26","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev.immunol.25.022106.141627","volume":"27","author":"SL Masters","year":"2009","unstructured":"Masters SL, Simon A, Aksentijevich I, Kastner DL. Horror Autoinflammaticus\u00a0: the molecular pathophysiology of autoinflammatory disease. Annu Rev Immunol. 2009;27:621\u201368. \n                    https:\/\/doi.org\/10.1146\/annurev.immunol.25.022106.141627\n                    \n                  .","journal-title":"Annu Rev Immunol"},{"key":"907_CR27","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.bone.2010.01.380","volume":"46","author":"CJ Wang","year":"2010","unstructured":"Wang CJ, Chen I-P, Koczon-Jaremko B, Boskey AL, Ueki Y, Kuhn L, et al. Pro416Arg cherubism mutation in Sh3bp2 knock-in mice affects osteoblasts and alters bone mineral and matrix properties. Bone. 2010;46:1306\u201315. \n                    https:\/\/doi.org\/10.1016\/j.bone.2010.01.380\n                    \n                  .","journal-title":"Bone"},{"key":"907_CR28","doi-asserted-by":"publisher","first-page":"140.e1","DOI":"10.1016\/j.ajodo.2009.05.021","volume":"138","author":"PM Mukherjee","year":"2010","unstructured":"Mukherjee PM, Wang CJ, Chen I-P, Jafarov T, Olsen BR, Ueki Y, et al. Cherubism gene Sh3bp2 is important for optimal bone formation, osteoblast differentiation, and function. Am J Orthod Dentofac Orthop. 2010;138:140.e1\u2013140.e11. \n                    https:\/\/doi.org\/10.1016\/j.ajodo.2009.05.021\n                    \n                   discussion 140\u20131.","journal-title":"Am J Orthod Dentofac Orthop"},{"key":"907_CR29","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1002\/jbmr.2295","volume":"29","author":"T Mukai","year":"2014","unstructured":"Mukai T, Ishida S, Ishikawa R, Yoshitaka T, Kittaka M, Gallant R, et al. SH3BP2 cherubism mutation potentiates TNF-\u03b1-induced osteoclastogenesis via NFATc1 and TNF-\u03b1-mediated inflammatory bone loss. J Bone Miner Res. 2014;29:2618\u201335. \n                    https:\/\/doi.org\/10.1002\/jbmr.2295\n                    \n                  .","journal-title":"J Bone Miner Res"},{"key":"907_CR30","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1601-0825.2010.01718.x","volume":"17","author":"Z Wang","year":"2011","unstructured":"Wang Z, McCauley LK. Osteoclasts and odontoclasts: signaling pathways to development and disease. Oral Dis. 2011;17:129\u201342. \n                    https:\/\/doi.org\/10.1111\/j.1601-0825.2010.01718.x\n                    \n                  .","journal-title":"Oral Dis"},{"key":"907_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cell.2006.12.019","volume":"128","author":"DV Novack","year":"2007","unstructured":"Novack DV, Faccio R. Jawing about TNF: new hope for cherubism. Cell. 2007;128:15\u20137. \n                    https:\/\/doi.org\/10.1016\/j.cell.2006.12.019\n                    \n                  .","journal-title":"Cell"},{"key":"907_CR32","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.bone.2012.10.003","volume":"52","author":"M Hero","year":"2013","unstructured":"Hero M, Suomalainen A, Hagstr\u00f6m J, Stoor P, Kontio R, Alapulli H, et al. Anti-tumor necrosis factor treatment in cherubism--clinical, radiological and histological findings in two children. Bone. 2013;52:347\u201353. \n                    https:\/\/doi.org\/10.1016\/j.bone.2012.10.003\n                    \n                  .","journal-title":"Bone"},{"key":"907_CR33","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1600-0714.2009.00855.x","volume":"39","author":"FR Amaral","year":"2010","unstructured":"Amaral FR, Brito JAR, Perdig\u00e3o PF, Carvalho VM, de Souza PEA, Gomez MV, et al. NFATc1 and TNFalpha expression in giant cell lesions of the jaws. J Oral Pathol Med. 2010;39:269\u201374. \n                    https:\/\/doi.org\/10.1111\/j.1600-0714.2009.00855.x\n                    \n                  .","journal-title":"J Oral Pathol Med"},{"key":"907_CR34","first-page":"147","volume":"29","author":"I Pagnini","year":"2011","unstructured":"Pagnini I, Simonini G, Mortilla M, Giani T, Pascoli L, Cimaz R. Ineffectiveness of tumor necrosis factor-alpha inhibition in association with bisphosphonates for the treatment of cherubism. Clin Exp Rheumatol. 2011;29:147.","journal-title":"Clin Exp Rheumatol"},{"key":"907_CR35","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s00198-010-1192-7","volume":"21","author":"CJ Edwards","year":"2010","unstructured":"Edwards CJ, Williams E. The role of interleukin-6 in rheumatoid arthritis-associated osteoporosis. Osteoporos Int. 2010;21:1287\u201393. \n                    https:\/\/doi.org\/10.1007\/s00198-010-1192-7\n                    \n                  .","journal-title":"Osteoporos Int"},{"key":"907_CR36","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1002\/art.22175","volume":"54","author":"F De Benedetti","year":"2006","unstructured":"De Benedetti F, Rucci N, Del Fattore A, Peruzzi B, Paro R, Longo M, et al. Impaired skeletal development in interleukin-6-transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system. Arthritis Rheum. 2006;54:3551\u201363. \n                    https:\/\/doi.org\/10.1002\/art.22175\n                    \n                  .","journal-title":"Arthritis Rheum"},{"key":"907_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S8756-3282(02)00915-8","volume":"32","author":"O Kudo","year":"2003","unstructured":"Kudo O, Sabokbar A, Pocock A, Itonaga I, Fujikawa Y, Athanasou N. Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism. Bone. 2003;32:1\u20137. \n                    https:\/\/doi.org\/10.1016\/S8756-3282(02)00915-8\n                    \n                  .","journal-title":"Bone"},{"key":"907_CR38","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3892\/ol.2011.274","volume":"2","author":"AP Duarte","year":"2011","unstructured":"Duarte AP, Gomes CC, Gomez RS, Amaral FR. Increased expression of NFATc1 in giant cell lesions of the jaws, cherubism and brown tumor of hyperparathyroidism. Oncol Lett. 2011;2:571\u20133. \n                    https:\/\/doi.org\/10.3892\/ol.2011.274\n                    \n                  .","journal-title":"Oncol Lett"},{"key":"907_CR39","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1196\/annals.1402.071","volume":"1116","author":"H Takayanagi","year":"2007","unstructured":"Takayanagi H. The role of NFAT in osteoclast formation. Ann N Y Acad Sci. 2007;1116:227\u201337. \n                    https:\/\/doi.org\/10.1196\/annals.1402.071\n                    \n                  .","journal-title":"Ann N Y Acad Sci"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0907-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-018-0907-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0907-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T19:08:55Z","timestamp":1568920135000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-018-0907-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,20]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["907"],"URL":"https:\/\/doi.org\/10.1186\/s13023-018-0907-2","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,20]]},"assertion":[{"value":"19 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An ethical approval and patient consent had been obtained for this study.The study had been approved by the ethical committee Paris 8 (Comit\u00e9 de Protection des Personnes Ile de France VIII).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Non-applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author declare that they have no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"166"}}